Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Depressive Disorder, Treatment-resistant”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT02122562
What this trial is testing

Ketamine Alcohol (in Treatment-Resistant Depression)

Who this might be right for
Magnetic Resonance ImagingMajor DepressionAlcoholism
Mark Niciu 60
Not applicableTemporarily pausedNCT04099342
What this trial is testing

Enhanced Spatial Targeting in ECT Utilizing FEAST

Who this might be right for
Treatment Resistant Depression
University of Minnesota 20
Not applicableStudy completedNCT06783361
What this trial is testing

Accelerated Transcranial Magnetic Stimulation in Treatment-Resistant Depressed Patients

Who this might be right for
Treatment Resistant Depression (TRD)Transcranial Magnetic StimulationAccelerated Protocol+3 more
Ataturk University 50
Testing effectiveness (Phase 2)Study completedNCT01998958
What this trial is testing

Evaluate the Safety and Efficacy of Intranasal Esketamine in Treatment-resistant Depression

Who this might be right for
Treatment Resistant Depressive Disorder
Janssen Research & Development, LLC 108
Not applicableStudy completedNCT04199143
What this trial is testing

Brain Reactivity to Nitrous Oxyde in Depression : an MRI and Ultrasound Study (PROTOBRAIN Pilote)

Who this might be right for
Treatment Resistant DepressionNitrous Oxyde
University Hospital, Tours 30
Testing effectiveness (Phase 2)UnknownNCT02622633
What this trial is testing

Epidural Stimulation for Resistant Depression Treatment

Who this might be right for
Major Depression
University of Brasilia 10
Early research (Phase 1)Looking for participantsNCT03522545
What this trial is testing

Adjunctive Allogeneic Mesenchymal Stem Cells for Treatment-resistant Bipolar Depression

Who this might be right for
Treatment-resistant Bipolar Depression
The University of Texas Health Science Center, Houston 30
Not applicableStudy completedNCT06730841
What this trial is testing

Dose-Optimized and Spaced Transcranial Direct Current Stimulation for Treatment-Resistant Depression

Who this might be right for
Treatment Resistant DepressionMajor Depressive Disorder
University of California, San Diego 3
Testing effectiveness (Phase 2)Study completedNCT02935595
What this trial is testing

Low Dose Intravenous Ketamine in Treatment Resistant Depression Patients

Who this might be right for
Treatment Resistant Depression
The University of Texas Health Science Center, Houston 9
Not applicableStudy completedNCT00953745
What this trial is testing

Dopaminergic Effects of Adjunctive Aripiprazole on the Brain in Treatment-Resistant Depression

Who this might be right for
Major Depressive Disorder
Washington University School of Medicine 43
Testing effectiveness (Phase 2)Study completedNCT00768430
What this trial is testing

Optimization of IV Ketamine for Treatment Resistant Depression

Who this might be right for
Major Depressive Disorder (MDD)Treatment Resistant Depression (TRD)
Baylor College of Medicine 73
Not applicableLooking for participantsNCT05900271
What this trial is testing

Dutch-Depression Outcome Trial Comparing 5 Day Multi Daily Neuronavigated Theta Burst Sessions With 6 Weeks rTMS

Who this might be right for
Treatment Resistant Depression
Amsterdam UMC, location VUmc 108
Not applicableUnknownNCT03626181
What this trial is testing

Biomarkers of Theta Burst Stimulation in Major Depressive Disorder

Who this might be right for
Depressive Disorder, Treatment-Resistant
University of Calgary 30
Early research (Phase 1)Study completedNCT03606395
What this trial is testing

Safety, Tolerability, PK and Efficacy of Single Doses of NV-5138 in Healthy Volunteers and Subjects With Treatment-Resistant Depression

Who this might be right for
Treatment Resistant Depression
Navitor Pharmaceuticals, Inc. 80
Not applicableStudy completedNCT02559466
What this trial is testing

Efficacy of Deep Transcranial Magnetic Stimulation (TMS) for Treatment-resistant Depression and Neuroanatomical Correlates: a Clinical Study Coupled With Positon Emission Tomography (PET)

Who this might be right for
Pharmacoresistant Depression
Assistance Publique Hopitaux De Marseille 45
Early research (Phase 1)Study completedNCT04032301
What this trial is testing

Repeated Ketamine Infusions for Comorbid PTSD and MDD in Veterans

Who this might be right for
Post-Traumatic Stress DisordersMajor Depressive Disorder
University of Minnesota 67
Large-scale testing (Phase 3)Study completedNCT04216095
What this trial is testing

Comparative Effectiveness Clinical Trial of MST Compared to ECT in Major Depressive Disorder

Who this might be right for
Major Depressive Disorder
Tanta University 60
Testing effectiveness (Phase 2)Study completedNCT01920555
What this trial is testing

Double-Blind, Placebo-Controlled Trial of Ketamine Therapy in Treatment-Resistant Depression (TRD)

Who this might be right for
Treatment Resistant Depression
Massachusetts General Hospital 99
Not applicableLooking for participantsNCT06528938
What this trial is testing

Comparing the Efficacy of Accelerated vs. Standard fMRI-guided iTBS in Treating Adolescents Depression

Who this might be right for
DepressionDepressive Disorder, Major
The Royal Ottawa Mental Health Centre 10
Large-scale testing (Phase 3)Ended earlyNCT01687478
What this trial is testing

Olanzapine and Fluoxetine for Treatment-resistant Depression

Who this might be right for
Treatment Resistant Depression
Eli Lilly and Company 176
Next Page